Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,450 | 35,389 | 37,198 | 28,275 | 54,090 |
| Marketable Securities | 38,532 | 61,387 | 72,753 | 77,736 | 67,737 |
| Receivables | 3,598 | 3,602 | 5,002 | 4,293 | 3,394 |
| Inventories | 1,776 | 1,000 | 600 | 1,649 | 821 |
| Other current assets | 0 | 0 | 9 | 0 | 8 |
| TOTAL | $78,803 | $103,719 | $117,649 | $114,352 | $128,495 |
| Non-Current Assets | |||||
| PPE Net | 7,452 | 7,551 | 7,644 | 9,135 | 9,236 |
| Investments And Advances | 0 | 741 | 11,655 | 22,376 | 29,157 |
| Other Non-Current Assets | 4,245 | 4,333 | 5,390 | 978 | 1,420 |
| TOTAL | $11,697 | $12,625 | $24,689 | $32,489 | $39,813 |
| Total Assets | $90,500 | $116,344 | $142,338 | $146,841 | $168,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,036 | N/A | N/A | 4,580 | 1,621 |
| Accounts payable and accrued liabilities | 23,507 | 23,043 | 20,327 | 19,617 | 18,338 |
| Accrued Expenses | 24,954 | 19,343 | 16,547 | 15,891 | 15,120 |
| TOTAL | $82,169 | $71,948 | $66,326 | $69,477 | $64,357 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,041 | 49,847 | 49,616 | 25,372 | 28,293 |
| Deferred Revenues | 221 | 221 | 221 | 221 | 200 |
| Other Non-Current Liabilities | 3,543 | 3,742 | 0 | 0 | 0 |
| TOTAL | $49,584 | $53,589 | $53,505 | $28,129 | $31,078 |
| Total Liabilities | $131,753 | $125,537 | $119,831 | $97,606 | $95,435 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,438 | 110,438 | 110,313 | 110,177 | 109,641 |
| Common Shares | 1,104 | 1,104 | 1,103 | 1,101 | 1,096 |
| Retained earnings | -838,006 | -800,414 | -762,785 | -731,969 | -704,537 |
| Other shareholders' equity | 60 | 41 | -89 | -297 | -410 |
| TOTAL | $-41,253 | $-9,193 | $22,507 | $49,235 | $72,873 |
| Total Liabilities And Equity | $90,500 | $116,344 | $142,338 | $146,841 | $168,308 |